Elevated driver mutational burden or number of perturbed pathways and poor response to abiraterone or enzalutamide in metastatic castration-resistant prostate cancer
| dc.contributor.author | De Laere, B | en_US |
| dc.contributor.author | Crippa, A | en_US |
| dc.contributor.author | Ghysel, C | en_US |
| dc.contributor.author | Ost, P | en_US |
| dc.contributor.author | Rajan, P | en_US |
| dc.contributor.author | Eklund, M | en_US |
| dc.contributor.author | Dirix, L | en_US |
| dc.contributor.author | Gronberg, H | en_US |
| dc.contributor.author | Lindberg, J | en_US |
| dc.date.accessioned | 2020-07-13T10:16:37Z | |
| dc.date.issued | 2019 | en_US |
| dc.identifier.issn | 0923-7534 | en_US |
| dc.identifier.uri | https://qmro.qmul.ac.uk/xmlui/handle/123456789/65621 | |
| dc.title | Elevated driver mutational burden or number of perturbed pathways and poor response to abiraterone or enzalutamide in metastatic castration-resistant prostate cancer | en_US |
| dc.type | Conference Proceeding | |
| pubs.author-url | https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000491295500319&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=612ae0d773dcbdba3046f6df545e9f6a | en_US |
| pubs.notes | Not known | en_US |
| pubs.publication-status | Published | en_US |
| pubs.volume | 30 | en_US |
| qmul.funder | Sam68 and hnRNPA2 in prostate cancer::Cancer Research UK | en_US |
Files in this item
| Files | Size | Format | View |
|---|---|---|---|
|
There are no files associated with this item. |
|||
